India’s leading Science-based Ayurveda major Dabur India Ltd announced a 7% growth in consolidated revenue for the first quarter of 2024-25 to Rs 3,349 crore, driven by steady growth across all key business verticals. The Q1 revenue growth stands at 10% on a constant currency basis.
The quarter saw sequential improvement in demand trends with rural growth picking up. With forecast of a normal monsoon and continued focus by the government on macro-economic growth, we expect the improvement to accelerate in the coming months.
BENGALURU, June 20 (Reuters) - India's markets regulator has asked Religare Enterprises (RELG.NS), opens new tab to apply for approvals to let the billionaire Burman family buy more shares in the financial services company, dealing a blow to the company's attempt to block the move.
Dabur India Limited has reported consolidated financial results for the period ended March 31, 2024.
BENGALURU, Nov 15 (Reuters) - Dabur India (DABU.NS) said on Wednesday a U.S. court had dismissed two of its three subsidiaries as defendants in a lawsuit tying the use of hair relaxer products to ovarian and uterine cancers as well as other health issues.
Dabur India`s units face lawsuits in US, Canada alleging products caused cancer
Dabur India Limited has reported total income of Rs. 3144.01 crores during the period ended December 31, 2022 as compared to Rs. 3109.77 crores during the period ended September 30, 2022. It reported total income of Rs.3038.49 crores during the period ended December 31, 2021.